Industry Insights
Deep dives on clinical endpoints, regulatory trends and data quality — written and curated by the EClinCloud team.
What Changed in the 2026 GCP? Understanding the Digital Thread Behind the Regulatory UpgradeOn June 8, 2026, the 2026 revised GCP was jointly issued by four ministries and commissions, taking effect on September 1 and marking the full alignment of China's clinical trial regulation with ICH E6(R3).
Visual Guide | What Regulatory Signal Is the FDA Sending with Real-Time Clinical Trials?In April 2026, the FDA announced the launch of its Real-Time Clinical Trials (RTCT) pilot. On the surface, this looks like a regulatory process optimization; however, viewed alongside the FDA's recently introduced HALO unified data platform and Elsa AI system, a deeper shift is underway:
Phase 3 Success, Yet Rejected by the FDA: Lessons for Clinical Endpoint AssessmentIn new drug development, every subtle shift in regulatory direction reverberates across the industry. EClinCloud closely tracks global drug review trends and evolving regulatory perspectives to deliver more reliable clinical endpoint assessment solutions.